Showing results (1201-1210 of 2,019) with videos related to
Sort By:
Pageof 202
Annals of Hepatology|April 13, 2015
Telaprevir may induce adverse cutaneous reactions by a T cell immune-mediated mechanismAlessandro Federico, Ernesto Aitella, Dolores Sgambato, et al.Annals of Hepatology|August 4, 2020
Increased serum selenium levels are associated with reduced risk of advanced liver fibrosis and all-cause mortality in NAFLD patients: National Health and Nutrition Examination Survey (NHANES) IIIMishal Reja, Michael Makar, Aayush Visaria, et al.Annals of Hepatology|July 17, 2020
Curcumin downregulates Smad pathways and reduces hepatic stellate cells activation in experimental fibrosisErika Hernández-Aquino, Marco A Quezada-Ramírez, Angélica Silva-Olivares, et al.Annals of Hepatology|April 13, 2015
Does hepatitis B virus coinfection have any impact on treatment outcome in hepatitis C patients on hemodialysis?Raul Carlos Wahle, Renata de Mello Perez, Christini Takemi Emori, et al.Annals of Hepatology|April 13, 2015
Exercise capacity of cirrhotic patients with hepatopulmonary syndromeJosé L Faustini-Pereira, Lucas Homercher-Galant, Eduardo Garcia, et al.Annals of Hepatology|April 13, 2015
IFNL3 polymorphisms and HCV infection in patients with beta thalassemiaRaffaella Origa, Giuseppe Marceddu, Fabrice Danjou, et al.Annals of Hepatology|April 13, 2015
Mycophenolic acid induces apoptosis of hepatic stellate cells in an in vitro model of HCVJan Best, Andreas Zahn, Anja Beilfuß, et al.Annals of Hepatology|May 14, 2011
Pathophysiological basis of albumin use in cirrhosisVicente Arroyo, Javier FernandezAnnals of Hepatology|September 14, 2011
Pre operative cardio pulmonary assessment of the liver transplant candidateGraciela Martinez-Palli, Andrés CárdenasAnnals of Hepatology|September 14, 2011
Genetic variation in interleukin-28B predicts SVR in hepatitis C genotype 1 Argentine patients treated with PEG IFN and ribavirinEzequiel Ridruejo, Angela Solano, Sebastián Marciano, et al.Pageof 202